# DIBBS #SPE2DP-26-T-5201

DLA Solicitation for Sumatriptan Succinate Injection (Glaxo Inc)

**Posted:** September 23, 2026
**Respond By:** September 28, 2026
**Identifier:** SPE2DP-26-T-5201
**NAICS:** 424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is soliciting Sumatriptan Succinate Injection for delivery to Fort Campbell, KY.
- Government Buyer:
  - Defense Logistics Agency (DLA)
  - DLA Troop Support Medical Supply Chain
  - Pharmaceutical Field Support Activity
- OEM Highlight:
  - Glaxo Inc is specified as the manufacturer
- Product Requested:
  - Sumatriptan Succinate Injection, 6 mg per unit
  - NSN 6505-01-374-5874
  - NDC 00173-0449-02
  - Packaged as 0.5 ml, 2 ml, 5s in commercial packaging
  - Quantity: 1 unit
- Delivery & Requirements:
  - Delivery required within 20 days to Fort Campbell, KY
  - Strict packaging, marking, and hazardous material handling requirements
  - Prohibition on covered defense telecommunications equipment
- No additional technical documents or option years specified

### Description

SUMATRIPTAN SUCCINA (QTY: 1, NSN: 6505-01-374-5874, Purchase Request: 7015749977)
  Approved Sources:
  - CAGE: 34006, Part No: NDC00173-0449-02
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5201)